| Recruiting | 3 | 5610 | RoW | Delamanid (DLM), Isoniazid (INH), Pyridoxine (vitamin B6) | National Institute of Allergy and Infectious Diseases (NIAID), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Otsuka Pharmaceutical Development & Commercialization, Inc. | Tuberculosis, MDR | 07/27 | 07/27 | | |
NCT05007821: Linezolid Dosing Strategies in Drug-Resistant TB |
|
|
| Active, not recruiting | 2 | 138 | RoW | Linezolid 600 mg, LZD, Linezolid 1200 mg (QD), Linezolid 1200 mg (TIW), Bedaquiline 200 mg, BDQ, Bedaquiline 100 mg, Delamanid 300 mg, DLM, Clofazimine 300 mg, CFZ, Clofazimine 100 mg | National Institute of Allergy and Infectious Diseases (NIAID) | Tuberculosis, Multidrug-Resistant, Tuberculosis, Tuberculosis, Pulmonary | 03/25 | 03/26 | | |
